Kularatne, R. N., Washington, K. E., Bulumulla, C., Calubaquib, E. L., Biewer, M. C., Oupicky, D., & Stefan, M. C. (2018). Histone Deacetylase Inhibitor (HDACi) Conjugated Polycaprolactone for Combination Cancer Therapy. Biomacromolecules.
Chicago-стиль цитированияKularatne, Ruvanthi N., Katherine E. Washington, Chandima Bulumulla, Erika L. Calubaquib, Michael C. Biewer, David Oupicky, and Mihaela C. Stefan. "Histone Deacetylase Inhibitor (HDACi) Conjugated Polycaprolactone for Combination Cancer Therapy." Biomacromolecules 2018.
MLA-цитированиеKularatne, Ruvanthi N., et al. "Histone Deacetylase Inhibitor (HDACi) Conjugated Polycaprolactone for Combination Cancer Therapy." Biomacromolecules 2018.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.